Google
GMED 株価分析 — Globus Medical (Healthcare >> Medical Devices)
GMED に関するよくある質問
GMEDのPER（株価収益率）は？
Globus Medical（GMED）は現在PER 18.57倍で取引されています。
GMEDのROE（自己資本利益率）は？
Globus MedicalのROEは12.40%です。
GMEDの配当利回りは？
Globus Medicalの配当利回りは0.00%です。
GMEDの品質スコア（Quality Score）は？
当社のAIはGMEDの総合財務品質を100点中85点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
GMEDは今が買い時ですか？
当社AIのタイミングスコアは100点中50点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
GMEDはどのセクターに属しますか？
Globus MedicalはHealthcare >> Medical Devicesセクターに分類されます（NYSE市場）
GMED AI Analysis Summary
Our AI summary for GMED: Globus Medical (NYSE), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 18.57, ROE of 12.40%, a dividend yield of 0.00%. Its financial Quality Score stands at 85/100 — fundamentals stronger than most of the market. The AI Timing Score is 50/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 78.79
Price
-1.47
(-1.83%)
Day Change
|
|
|---|
GMED, ファンダメンタルスコアはvery good ( ファンダメンタル = 85) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROEが低い
平均ROEが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
790
|
| Magic Formula Rank by ROE |
790
|
| Magic Formula Rank by ROIC |
956
|
| Price | 78.79 |
| PBV / Sector |
2.30 / -101.57
|
| Earning Per Share | 4.24 |
| PE / Sector |
18.57 / 31.23
|
| PEG or PE/Growth / Sector |
0.16 / 0.40
GREAT
|
| Average 1M Daily Value |
126.19 M
GREAT
|
| Average 1W Daily Value |
92.17 M
|
| Timing Factors |
|
42% |
| Financial Health |
|
47% |
| ポイントになる統計 |
|
64% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:54 |
| Symbol | GMED |
| Name | GLOBUS MEDICAL |
| Sector | Healthcare >> Medical Devices |
| Market | NYSE |
| Listed Shares | 113.31 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 10,894.86 / 20,104.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2560 General Armistead Avenue, Audubon, PA, United States, 19403-5214
Phone: 610 930 1800
Website: https://www.globusmedical.com
Employees: 6,000
Sector: Healthcare >> Medical Devices
Description: Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
